Buy Lupin, price target Rs 580: Shrikant Chouhan
The analyst suggested a stoploss at Rs 540 .

Lupin Ltd., incorporated in 1983, is a largecap company with a market cap of Rs 25284.09 crore.
Lupin's key products/revenue segments include Pharmaceuticals which contributed Rs 10657.32 crore to sales value (93.84 per cent of total sales), Export Incentives which contributed Rs 250.66 crore to sales value (2.20 per cent of total sales) and Other Operating Revenue which contributed Rs 74.10 crore to sales value (0.65 per cent of total sales) for the year ending March 31, 2019.
For the quarter ended December 31, 2019, the company reported consolidated sales of Rs 3716.09 crore, down -13.52 per cent from last quarter sales of Rs 4296.90 crore and down -15.12 per cent from last year same quarter sales of Rs 4377.94 crore. The company reported net profit after tax of Rs -841.36 crore in the latest quarter.
Download ET Markets APP